BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35209182)

  • 1. Molecular Pathological Diagnosis of Thyroid Tumors Using Spatially Resolved Metabolomics.
    Huang L; Mao X; Sun C; Li T; Song X; Li J; Gao S; Zhang R; Chen J; He J; Abliz Z
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A graphical data processing pipeline for mass spectrometry imaging-based spatially resolved metabolomics on tumor heterogeneity.
    Huang L; Mao X; Sun C; Luo Z; Song X; Li X; Zhang R; Lv Y; Chen J; He J; Abliz Z
    Anal Chim Acta; 2019 Oct; 1077():183-190. PubMed ID: 31307708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatially Resolved Metabolomics Based on Air-Flow-Assisted Desorption Electrospray Ionization-Mass Spectrometry Imaging Reveals Region-Specific Metabolic Alterations in Diabetic Encephalopathy.
    Huo M; Wang Z; Fu W; Tian L; Li W; Zhou Z; Chen Y; Wei J; Abliz Z
    J Proteome Res; 2021 Jul; 20(7):3567-3579. PubMed ID: 34137614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Thyroid Tumors Based on Mass Spectrometry Imaging of Tissue Microarrays; a Single-Pixel Approach.
    Kurczyk A; Gawin M; Chekan M; Wilk A; Łakomiec K; Mrukwa G; Frątczak K; Polanska J; Fujarewicz K; Pietrowska M; Widlak P
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ biomarker discovery and label-free molecular histopathological diagnosis of lung cancer by ambient mass spectrometry imaging.
    Li T; He J; Mao X; Bi Y; Luo Z; Guo C; Tang F; Xu X; Wang X; Wang M; Chen J; Abliz Z
    Sci Rep; 2015 Sep; 5():14089. PubMed ID: 26404114
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wang Z; He B; Liu Y; Huo M; Fu W; Yang C; Wei J; Abliz Z
    Acta Pharm Sin B; 2020 Jun; 10(6):1083-1093. PubMed ID: 32642414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Diagnostic Metabolic Signatures in Thyroid Tumors Using Mass Spectrometry Imaging.
    Mao X; Huang L; Li T; Abliz Z; He J; Chen J
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry.
    Prade VM; Kunzke T; Feuchtinger A; Rohm M; Luber B; Lordick F; Buck A; Walch A
    Mol Metab; 2020 Jun; 36():100953. PubMed ID: 32278304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.
    Neumann JM; Niehaus K; Neumann N; Knobloch HC; Bremmer F; Krafft U; Kellner U; Nyirády P; Szarvas T; Bednarz H; Reis H
    Lab Invest; 2021 Sep; 101(9):1281-1288. PubMed ID: 34021261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
    Ucal Y; Tokat F; Duren M; Ince U; Ozpinar A
    Thyroid; 2019 Aug; 29(8):1125-1137. PubMed ID: 31064269
    [No Abstract]   [Full Text] [Related]  

  • 11. Follicular adenomas exhibit a unique metabolic profile. ¹H NMR studies of thyroid lesions.
    Deja S; Dawiskiba T; Balcerzak W; Orczyk-Pawiłowicz M; Głód M; Pawełka D; Młynarz P
    PLoS One; 2013; 8(12):e84637. PubMed ID: 24376829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.
    Pietrowska M; Diehl HC; Mrukwa G; Kalinowska-Herok M; Gawin M; Chekan M; Elm J; Drazek G; Krawczyk A; Lange D; Meyer HE; Polanska J; Henkel C; Widlak P
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):837-845. PubMed ID: 27760391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging.
    Wang Z; Fu W; Huo M; He B; Liu Y; Tian L; Li W; Zhou Z; Wang B; Xia J; Chen Y; Wei J; Abliz Z
    Acta Pharm Sin B; 2021 Nov; 11(11):3665-3677. PubMed ID: 34900545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatially Resolved Metabolomics Method for Mapping the Global Molecular Landscape of Whole-Body Zebrafish (
    Sun Y; Zhou Z; Xie B; Wang Z; Abliz Z
    Anal Chem; 2023 Jun; 95(24):9164-9172. PubMed ID: 37264941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
    Guo S; Qiu L; Wang Y; Qin X; Liu H; He M; Zhang Y; Li Z; Chen X
    Anal Bioanal Chem; 2014 Jul; 406(18):4357-70. PubMed ID: 24842401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
    J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
    Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics for the diagnosis of thyroid lesions: preliminary report.
    Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
    Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive high-resolution mass spectrometry approach for characterization of metabolites by combination of ambient ionization, chromatography and imaging methods.
    Berisha A; Dold S; Guenther S; Desbenoit N; Takats Z; Spengler B; Römpp A
    Rapid Commun Mass Spectrom; 2014 Aug; 28(16):1779-91. PubMed ID: 25559448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.